CIML NK Cell in Head & Neck Cancer

Clinical trial NCT04290546 · COMPLETED

Trial details

NCT number: NCT04290546
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck Recurrent Head and Neck Squamous Cell Carcinoma

Start date: 2020-07-20
Primary completion: 2024-09-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.